Cardiff Oncology Stock Forecast

Stock Price Forecast

According to 4 professional analysts, the 12-month price target for Cardiff Oncology stock ranges from a low of $3.50 to a high of $19. The average analyst price target of $10.63 forecasts a 403.79% increase in the stock price over the next year.

Price Target: $10.63 (+403.79%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$3.50	$10.63	$10	$19
Change	+65.88%	+403.79%	+373.93%	+800.47%

* Price targets were last updated on Aug 6, 2025.

Analyst Ratings

The average analyst rating for Cardiff Oncology stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jun '25	Jul '25	Aug '25	Sep '25	Oct '25	Nov '25
Strong Buy	3	4	4	4	4	2
Buy	1	1	1	1	1	1
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	5	6	6	6	6	4

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Robert Burns HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $18 → $10	Strong Buy	Maintains	$18 → $10	+373.93%	Aug 6, 2025
Kevin DeGeeter Ladenburg Thalmann	Ladenburg Thalmann	Strong Buy Initiates $19	Strong Buy	Initiates	$19	+800.47%	Jul 8, 2025
Maury Raycroft Jefferies	Jefferies	Hold Initiates $3.5	Hold	Initiates	$3.5	+65.88%	Jun 24, 2025
Robert Burns HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $17 → $18	Strong Buy	Maintains	$17 → $18	+753.08%	May 9, 2025
Robert Burns HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $13 → $17	Strong Buy	Maintains	$13 → $17	+705.69%	Feb 28, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

469.20K

from 683.00K

-31.30%

from 683.00K

Revenue Next Year

331.50K

from 469.20K

-29.35%

from 469.20K

EPS This Year

-0.79

from -0.95

EPS Next Year

-0.77

from -0.79

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	366.00K	359.00K	386.00K	488.00K	683.00K	469.20K	331.50K
Revenue Growth	49.61%	-1.91%	7.52%	26.42%	39.96%	-31.30%	-29.35%
EPS	-1.08	-0.73	-0.89	-0.93	-0.95	-0.79	-0.77
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	-	-
No. Analysts	-	-	-	-	-	10	10

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026
High	525,000	630,000
Avg	469,200	331,500
Low	343,000	n/a

Revenue Growth

Revenue Growth	2025	2026
High	-23.1%	34.3%
Avg	-31.3%	-29.3%
Low	-49.8%	-

EPS Forecast

EPS	2025	2026
High	-0.78	-0.58
Avg	-0.79	-0.77
Low	-0.82	-0.95

EPS Growth

EPS Growth	2025	2026
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.